ArticleAJOG global reports2025
Transradial uterine artery embolization for the treatment of symptomatic fibroids: A ten year experience.
Article in AJOG global reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transradial access in interventional gynecology and obstetrics: Current evidence, clinical applications, and future directions.European journal of obstetrics & gynecology and reproductive biology: X · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUterine fibroids are the most common tumors in women. They are generally asymptomatic but can cause bleeding problems and/or compression of neighboring structures and infertility. Embolization is an effective treatment for fibroids. However, transradial access is underused for various reasons.
objectiveThis study aimed to demonstrate that transradial access is safe and effective for treating symptomatic uterine fibroids to avoid the need for conventional surgery. STUDY
designA single-center retrospective observational study of medical records between 2012 and 2022, in which 189 procedures were planned in patients with symptomatic uterine fibroids with fulfilled gestational desire, was conducted. The feasibility and safety of the technique, the need for subsequent surgery because of the lack of effectiveness of the treatment in women who could complete it from the date of the procedure until 24 months later, changes in uterine volume and in the largest fibroid, and changes in hemoglobin levels, follicle-stimulating hormone, luteinizing hormone, and estradiol were analyzed before and 6 months after the procedure. Changes in the quality of life questionnaire (Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire) were analyzed before embolization and at 2 and 6 months after embolization.
resultsOf note, 184 of 189 procedures (97.35%) were performed with total or partial angiographic success. Surgical intervention was not necessary 24 months after the procedure in 85.4% of patients (158/180 patients with complete angiographic success) with a very low rate of complications, all of them mild (13/185 [7%]). Between the first visit and the visit at 6 months after the intervention, both the uterine volume decreased (n=176; previous volume, 458.11 mL; volume after 6 months, 311.87 mL; -146.24 mL [95% confidence interval, -115.41 to -177.06];
conclusionThe transradial approach should be adopted as a safe and effective alternative for the treatment of symptomatic uterine fibroids in patients with fulfilled gestational desire.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.